Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Escitalopram oxalate
Drug ID BADD_D00810
Description Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]
Indications and Usage Labeled indications include major depressive disorder (MDD) and generalized anxiety disorder (GAD). Unlabeled indications include treatment of mild dementia-associated agitation in nonpsychotic patients.
Marketing Status Prescription
ATC Code N06AB10
DrugBank ID DB01175
KEGG ID D02567
MeSH ID D000089983
PubChem ID 146571
TTD Drug ID D08RBC
NDC Product Code 71335-0322; 68071-3265; 55289-828; 43063-761; 71205-313; 55111-944; 58032-0134; 70966-0032; 70934-089; 71052-647; 65862-373; 59746-279; 65372-1143; 68084-617; 68084-618; 65862-411; 0904-6427; 61919-139; 68071-2597; 45562-1130; 59746-280; 71205-168; 65372-1116; 22365-115; 53104-7565; 65862-375; 65015-886; 70934-163; 71205-193; 55154-6893; 70518-1291; 68788-6978; 0456-2021; 65162-019; 13668-136; 17856-0551; 51672-1348; 50090-5112; 65162-020; 65862-374; 0904-6426; 68001-197; 16571-769; 31722-569; 68001-196; 13668-135; 55154-7288; 70934-060; 68554-0007; 71335-0658; 65862-248; 68001-195; 51686-0011; 64220-109; 0456-2006; 0456-2011; 71335-0685; 72761-009; 65162-021; 59746-281; 61919-227; 13668-137; 50090-5131; 55289-768; 63629-8042; 63629-2981; 65691-0066; 70518-0791; 45865-996; 42708-077
Synonyms Escitalopram | Escitalopram Oxalate | Lexapro
Chemical Information
Molecular Formula C22H23FN2O5
CAS Registry Number 219861-08-2
SMILES CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal pain07.01.05.002--
Abnormal dreams19.02.03.001; 17.15.02.001--Not Available
Abortion spontaneous18.01.04.001--Not Available
Acute psychosis19.03.01.001--Not Available
Aggression19.05.01.001--Not Available
Agitation17.02.05.012; 19.06.02.001--
Agranulocytosis01.02.03.001--Not Available
Akathisia19.06.02.006; 17.01.02.002--
Alopecia23.02.02.001--
Amnesia19.20.01.001; 17.03.02.001--
Anaemia01.03.02.001--
Anaphylactic reaction24.06.03.006; 10.01.07.001--
Anger19.04.02.001--Not Available
Angioedema23.04.01.001; 10.01.05.009--Not Available
Anorgasmia19.08.01.001--
Anxiety19.06.02.002--
Apathy19.04.04.002--Not Available
Aplastic anaemia01.03.03.002--Not Available
Arthralgia15.01.02.001--
Asthenia08.01.01.001--Not Available
Ataxia17.02.02.001; 08.01.02.004--
Atrial fibrillation02.03.03.002--
Blood bilirubin increased13.03.01.008--
Blood pressure diastolic13.14.03.021--Not Available
Blood pressure systolic13.14.03.012--Not Available
Bradycardia02.03.02.002--Not Available
Bronchitis22.07.01.001; 11.01.09.001--
Cardiac failure02.05.01.001--
Cerebrovascular accident24.03.05.001; 17.08.01.007--
Chest pain22.02.08.003; 08.01.08.002; 02.02.02.011--Not Available
The 1th Page    1 2 3 4 5    Next   Last    Total 7 Pages